Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.50    1.50 (2.14%)
Bid:
71.00
Ask:
72.00
Spread: 1.00 (1.408%)
Market Cap: £325.40m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Total Voting Rights

21 Dec 2006 08:44

Avacta Group plc (the "Company")

Total Voting Rights

In conformity with the Transparency Directive's transitional provision 6, the Company notifies the market of the following:

As at the date of this announcement, the Company's issued share capital consists of 669,327,342 ordinary shares with a nominal value of 0.1 pence each ("Ordinary Shares"), with voting rights. The Company does not hold any Ordinary Shares in Treasury.

Therefore, the total number of Ordinary Shares with voting rights is 669,327,342.

The above figure of 669,327,342 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

Enquiries:Avacta Group plc 0870 835 4367 Tim Sykes, Chief Financial Officer Nexus Financial Ltd 020 7451 7068 Nicholas Nelson WH Ireland Limited 0161 832 2174 David Youngman

AVACTA GROUP PLC
Date   Source Headline
15th Jun 20204:36 pmRNSPrice Monitoring Extension
15th Jun 20202:05 pmRNSSecond Price Monitoring Extn
15th Jun 20202:00 pmRNSPrice Monitoring Extension
15th Jun 202011:05 amRNSSecond Price Monitoring Extn
15th Jun 202011:00 amRNSPrice Monitoring Extension
12th Jun 20207:00 amRNSHolding(s) in Company
10th Jun 20206:35 pmRNSHolding(s) in Company
9th Jun 20207:01 amRNSInvestor Presentation
9th Jun 20207:00 amRNSUpdate on COVID-19 Test Development with Adeptrix
8th Jun 20204:15 pmRNSPosting of Circular and Notice of General Meeting
4th Jun 20205:16 pmRNSDirector/PDMR Shareholding
4th Jun 20205:15 pmRNSResult of Fundraising
4th Jun 202012:30 pmRNSIncrease in Fundraising
4th Jun 202011:05 amRNSSecond Price Monitoring Extn
4th Jun 202011:00 amRNSPrice Monitoring Extension
4th Jun 20209:05 amRNSSecond Price Monitoring Extn
4th Jun 20209:00 amRNSPrice Monitoring Extension
4th Jun 20207:01 amRNSPrimaryBid.com Offers
4th Jun 20207:00 amRNSProposed Fundraising to raise up to £45 million
28th May 20207:00 amRNSPosting of Annual Report and Notice of AGM
26th May 202011:05 amRNSSecond Price Monitoring Extn
26th May 202011:00 amRNSPrice Monitoring Extension
26th May 20208:06 amRNSIssue of Equity
21st May 20202:05 pmRNSSecond Price Monitoring Extn
21st May 20202:00 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSDistribution Agreement for COVID-19 Antigen Test
15th May 20204:41 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
15th May 20202:06 pmRNSSecond Price Monitoring Extn
15th May 20202:00 pmRNSPrice Monitoring Extension
15th May 202011:06 amRNSSecond Price Monitoring Extn
15th May 202011:00 amRNSPrice Monitoring Extension
15th May 20209:30 amRNSIssue of Equity
15th May 20207:00 amRNSSARS-COV-2 Neutralising Affimers
11th May 20207:00 amRNSAvacta Ships SARS-COV-2 Affimer Reagents
6th May 20207:00 amRNSResults for the period ending 31 December 2019
5th May 20206:15 pmRNSHolding(s) in Company
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSCOVID-19 Antigen Test Collaboration with Adeptrix
27th Apr 20205:30 pmRNSHolding(s) in Company
27th Apr 20205:00 pmRNSHolding(s) in Company
24th Apr 20206:00 pmRNSHolding(s) in Company
24th Apr 20204:41 pmRNSSecond Price Monitoring Extn
24th Apr 20204:36 pmRNSPrice Monitoring Extension
24th Apr 20202:05 pmRNSSecond Price Monitoring Extn
24th Apr 20202:00 pmRNSPrice Monitoring Extension
23rd Apr 20204:40 pmRNSSecond Price Monitoring Extn
23rd Apr 20204:35 pmRNSPrice Monitoring Extension
23rd Apr 202010:18 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.